Skip to main content
. 2024 Mar 21;25(6):3547. doi: 10.3390/ijms25063547

Table 4.

Comparison of E-cadherin and N-cadherin expression depending on the tissue location (tumor vs. the endocervix) and histological type of endometrial cancer (type I vs. II). Data are presented as n (%). * χ2 test, p-values < 0.05 were considered statistically significant; p1—p-value for cadherin expression depending on the location; p2—p-value for cadherin expression in the endocervix depending on the type of endometrial cancer; p3—p-value for cadherin expression in the tumor depending on the type of endometrial cancer.

Endometrial Cancer Expression in the Tumor Expression in the Endocervix
E-Cadherin N-Cadherin
Low High p1 * p2 * p3 * Low High p1 * p2 * p3 *
Type I Low 28 (55) 3 (6) 0.29 <0.001 0.001 4 (8) 4 (8) 0.59 0.19 0.29
High 16 (31) 4 (8) 26 (51) 17 (33)
Type II Low 13 (26) 2 (4) 0.01 11 (22) 1 (2) <0.001
High 13 (26) 22 (44) 12 (24) 26 (52)